The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective: The study’s aim was to develop and standardize a Korean version of the University of California San Diego Performance-based Skills Assessment (K-UPSA), which is used to evaluate the daily living function of patients with schizophrenia. Methods: Study participants were 78 patients with schizophrenia and 27 demographically matched healthy controls. We evaluated the clinical states and cognitive functions to verify K-UPSA’s reliability and validity. For clinical states, the Positive and Negative Syndrome Scale, Clinical Global Impression-Schizophrenia scale, and Social and Occupational Functioning Assessment Scale and Schizophrenia Quality of Life Scale-fourth revision were used. The Schizophrenia Cognition Rating Scale, Short-form of Korean-Wechsler Adult Intelligence Scale, and Wisconsin Card Sorting Test were used to assess cognitive function. Results: The K-UPSA had statistically significant reliability and validity. The K-UPSA has high internal consistency (Cronbach’s alpha, 0.837) and test-retest reliability (intra-class correlation coefficient, 0.381-0.792; p<0.001). The K-UPSA had significant discriminant validity (p<0.001). Significant correlations between the K-UPSA’s scores and most of the scales and tests listed above demonstrated K-UPSA’s concurrent validity (p<0.001). Conclusion: The K-UPSA is useful to evaluate the daily living function in Korean patients with schizophrenia.
Abstract
Objective: The study’s aim was to develop and standardize a Korean version of the University of California San Diego Performance-based Skills Assessment (K-UPSA), which is used to evaluate the daily living function of patients with schizophrenia. Methods: Study participants were 78 patients with schizophrenia and 27 demographically matched healthy controls. We evaluated the clinical states and cognitive functions to verify K-UPSA’s reliability and validity. For clinical states, the Positive and Negative Syndrome Scale, Clinical Global Impression-Schizophrenia scale, and Social and Occupational Functioning Assessment Scale and Schizophrenia Quality of Life Scale-fourth revision were used. The Schizophrenia Cognition Rating Scale, Short-form of Korean-Wechsler Adult Intelligence Scale, and Wisconsin Card Sorting Test were used to assess cognitive function. Results: The K-UPSA had statistically significant reliability and validity. The K-UPSA has high internal consistency (Cronbach’s alpha, 0.837) and test-retest reliability (intra-class correlation coefficient, 0.381-0.792; p<0.001). The K-UPSA had significant discriminant validity (p<0.001). Significant correlations between the K-UPSA’s scores and most of the scales and tests listed above demonstrated K-UPSA’s concurrent validity (p<0.001). Conclusion: The K-UPSA is useful to evaluate the daily living function in Korean patients with schizophrenia.
참고문헌 (37)
- Velligan DI, "The functional significance of symptomatology and cognitive function in schizophrenia", Schizophr Res, 25, pp.21~31 (1997)
- Wu EQ, "The economic burden of schizophrenia in the United States in 2002", J Clin Psychiatry, 66, pp.1122~1129 (2005)
- 장성만, "Economic Burden of Schizophrenia in South Korea", Journal of Korean Medical Science, 23(2), pp.167~175 (2008), 대한의학회
- Korea Employment Agency for the Disabled, "Panoptically 2016 disability statistics" (2016), Korea Employment Agency for the Disabled
- Green MF, "Longitudinal studies of cognition and functional outcome in schizophrenia : implications for MATRICS", Schizophr Res, 72, pp.41~51 (2004)
- Yoshio Kaneko, "Cognitive Remediation in Schizophrenia", Clinical Psychopharmacology and Neuroscience, 10(3), pp.125~135 (2012), 대한정신약물학회
- Evans JD, "The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients", Biol Psychiatry, 53, pp.422~430 (2003)
- Malla AK, "Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis", Psychol Med, 32, pp.1109~1119 (2002)
- Bell MD, "Work rehabilitation in schizophrenia:does cognitive impairment limit improvement?", Schizophr Bull, 27, pp.269~279 (2001)
- American Psychiatric Association DSM Task Force, "Diagnostic and Statistical Manual of Mental Disorders" (2013), American Psychiatric Association
- Patterson TL, "UCSD Performance-Based Skills Assessment : development of a new measure of everyday functioning for severely mentally ill adults", Schizophr Bull, 27, pp.235~245 (2001)
- Bellack AS, "Evaluation of social problem solving in schizophrenia", J Abnorm Psychol, 103, pp.371~378 (1994)
- Harvey PD, "Latest developments in the matrics process", Psychiatry(Edgmont), 7, pp.49~52 (2010)
- Mausbach BT, "Relationship between functional capacity and community responsibility in patients with schizophrenia : differences between independent and assisted living settings", Community Ment Health J, 44, pp.385~391 (2008)
- Twamley EW, "Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis", Am J Psychiatry, 159, pp.2013~2020 (2002)
- Gonzalez JM, "A qualitative assessment of cross-cultural adaptation of intermediate measures for schizophrenia in multisite international studies", Psychiatry Res, 206, pp.166~172 (2013)
- Velligan DI, "The cultural adaptability of intermediate measures of functional outcome in schizophrenia", Schizophr Bull, 38, pp.630~641 (2012)
- Gardner DM, "International consensus study of antipsychotic dosing", Am J Psychiatry, 167, pp.686~693 (2010)
- Rey MJ, "Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics", Int Clin Psychopharmacol, 4, pp.95~104 (1989)
- Bonett DG, "Sample size requirements for estimating pearson, kendall and spearman correlations", Psychometrika, 65, pp.23~28 (2000)
- Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Haro JM, "The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia", Acta Psychiatr Scand Suppl, (416), pp.16~23 (2003)
- Goldman HH, "Revising axis V for DSM-IV : a review of measures of social functioning", Am J Psychiatry, 149, pp.1148~1156 (1992)
- Martin CR, "Factor structure of the Schizophrenia Quality of Life Scale Revision 4(SQLS-R4)", Psychol Health Med, 12, pp.126~134 (2007)
- 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
- 김진훈, "한국어판 정신분열병 삶의 질 척도의 개발과 PANSS와의 관련성", 신경정신의학, 45(5), pp.401~410 (2006), 대한신경정신의학회
- Keefe RS, "The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity", Am J Psychiatry, 163, pp.426~532 (2006)
- Allen DN, "Utility of WAIS-R short forms in schizophrenia", Schizophr Res, 26, pp.163~172 (1997)
- Berg EA, "Wisconsin Card Sorting Test" (1993), Psychological Assessment Resources
- Liddle PF, "Schizophrenic syndromes, cognitive performance and neurological dysfunction", Psychol Med, 17, pp.49~57 (1987)
- Addington J, "Cognitive functioning and positive and negative symptoms in schizophrenia", Schizophr Res, 5, pp.123~134 (1991)
- Üçok A, "Employment and its relationship with functionality and quality of life in patients with schizophrenia : EGOFORS Study", Eur Psychiatry, 27, pp.422~425 (2012)
- Ritsner MS, "Predicting quality of life impairment in chronic schizophrenia from cognitive variables", Qual Life Res, 16, pp.929~937 (2007)
- Erlenmeyer-Kimling L, "Attention, memory, and motor skills as childhood predictors of schizophreniarelated psychoses: the New York High-Risk Project", Am J Psychiatry, 157, pp.1416~1422 (2000)
- Fujii DE, "Neurocognition and longterm prediction of quality of life in outpatients with severe and persistent mental illness", Schizophr Res, 69, pp.67~73 (2004)
- 김성진, "The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia", Clinical Psychopharmacology and Neuroscience, 13(3), pp.288~295 (2015), 대한정신약물학회
- Keefe RS, "Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale", Eur Neuropsychopharmacol, 25, pp.176~184 (2015)
